Portfolio (Quarterly)
Guide ↗
Remedium Capital Partners, LLC
· CIK 0002104501| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics Inc | Healthcare | 1,565,661.0 | $149.0M | 32.99% | -323K | -17.1% | $95.17 | +7.0% |
| 2 | SYRE | Spyre Therapeutics Inc | Healthcare | 1,464,169.0 | $130.0M | 28.78% | -443K | -23.2% | $88.78 | +20.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%